MicroRNAs as Potential Regulators of GSK-3β in Renal Cell Carcinoma
Masaki Murata(Niigata Prefectural Central Hospital), Yoshihiko Tomita(Niigata University Medical and Dental Hospital)
Cited by 2
Related Papers
Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma
|British Journal of Cancer|2009|107
9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer
|Scientific Reports|2019|60
Double inhibition of XIAP and Bcl-2 axis is beneficial for retrieving sensitivity of renal cell cancer to apoptosis
|British Journal of Cancer|2008|49